A survey conducted by the leading journal 'Preventive Medicine' paints a grim picture for the ‘obese’ women. The survey suggests that obesity is a curse on a woman's life.
According to researchers at the University of Connecticut, obese women are more likely to be fired from their job or get in trouble with the police than thin ones.
It is also stated that they are more likely to be criminals themselves.
Most disturbingly, the survey predicts that the overweight women also suffer the most stress as compared to obese men.
A new study in the November issue of Journal of American Geriatrics Society revealed that parents who live to be 100 may pass on the "good genes" to their children. The study which is the first to examine the health of centenarian offspring, found that these children tended to live longer and were substantially less likely to develop diabetes or suffer a heart attack or stroke over four years.
In what is being seen as a revolutionary innovation that will allow patients, paralyzed in accidents which damage the spine, to relearn how to move. A group of engineers in the UK have contributed to the development of a micro technology that could well enable amputees to move artificial limbs through the power of their brains. 
Results of a new rodent study suggest that a daily exercise routine helps not only in keeping excess weight at bay but it can also reverse age related memory decline. Natural age related memory decline is due to a decline in the production of neural stem cells in the hippocampus of the brain. This is a part of the brain which plays a key role in perking-up memory and learning and this slow down in brain cell production is linked to impaired memory and learning. 
Shreya Life Sciences announced the launch of the world's first oral insulin spray as an alternative to the insulin injections. Launched under the brand name, "Oral Recosulin", the spray is a recombinant DNA human insulin buccal spray and has been approved for marketing in India while in the U. S. it is in Phase 3 of the trials. Mr Ram Shelat, Director Shreya Life Sciences said, "It has been approved for marketing in India. We are waiting for price approval, and by the first week of December, it will be available in the Indian market." 
